<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02145520</url>
  </required_header>
  <id_info>
    <org_study_id>12216/12</org_study_id>
    <secondary_id>12216/12</secondary_id>
    <nct_id>NCT02145520</nct_id>
  </id_info>
  <brief_title>Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis</brief_title>
  <official_title>Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamad Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hamad Medical Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, investigators will compare the efficacy and safety of intravenous (IV)&#xD;
      Magnesium sulfate in decreasing bronchiolitis clinical severity score and the duration of&#xD;
      hospitalization in admitted patients, as compared to placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  On arrival to Pediatric Emergency Center, patients will be attended by a pediatric&#xD;
           specialist on call who will take history and perform full physical examination. Patients&#xD;
           will be assessed for eligibility to the study based on the inclusion criteria.&#xD;
&#xD;
        -  Guardians of eligible patients will be approached with the study design, objectives and&#xD;
           risks; Patients will be included after obtaining a verbal and assigned written consent.&#xD;
&#xD;
        -  A chest radiograph and Magnesium level in serum will be requested for all study patients&#xD;
           upon recruitment.&#xD;
&#xD;
        -  The observation physician will complete the data collection sheet that will include the&#xD;
           patient's demographics, physical examination, bronchiolitis clinical severity&#xD;
           score,oxygen saturation, chest radiograph findings and Magnesium level.&#xD;
&#xD;
        -  Treatment will be delivered to enrolled patients as currently practice in PEC(Nebulized&#xD;
           epinephrine 1:1000 1ml in 5 ml of 5% hypertonic saline, every 4 hours until discharge,&#xD;
           for all patients and if there is history of Bronchial Asthma in mother, father or full&#xD;
           sibling. And/or history of Eczema in the Child ,patients will start on dexamethasone&#xD;
           1mg/kg orally stat.(max-10 mg/dose). Then 0,6 mg/kg orally once daily starting from&#xD;
           second day of admission for 4 days).&#xD;
&#xD;
        -  All patients will be randomized to receive either Magnesium sulfate intravenous single&#xD;
           dose over 1 hour or placebo. And it will be given in the same time with currently&#xD;
           practice treatment&#xD;
&#xD;
        -  Epinephrine nebulization can be given on PRN basis up to a maximum of every one hour, at&#xD;
           a dose of 0.5 mg/kg (min 2.5mg/dose and max 5 mg/dose) mixed in 5 ml of 5% hypertonic&#xD;
           saline.•&#xD;
&#xD;
        -  Bronchiolitis severity score (BSS) will be recorded at 0, 4, 8, 12, 16,20,24,36,48,60,72&#xD;
           hours, and on discharge.&#xD;
&#xD;
        -  Vital signs will be recorded at 0, 2, 4 hours and then every 4 hours from the&#xD;
           administration of study medication.&#xD;
&#xD;
        -  All patients will be followed up for two weeks post discharge by a phone call asking&#xD;
           about the general condition, relapse of symptoms, or need for readmission.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement Percentage of Discharge After a Dose of IV Magnesium sulfate</measure>
    <time_frame>Time to medical readiness for discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of bronchiolitis clinical severity score</measure>
    <time_frame>2 Weeks</time_frame>
    <description>Need for admission to ICU during the initial visit&#xD;
Within 2 weeks after discharge:&#xD;
Need for clinical revisit&#xD;
Need for infirmary/observation unit admission&#xD;
Need for ICU admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Bronchiolitis</condition>
  <condition>Magnesium, Abnormal Blood Level</condition>
  <arm_group>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Magnesium sulfate. Single dose intravenous over one hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Treatment will be delivered to enrolled patients as currently practice in PEC (Epinephrine nebulization +5%hypertonic saline with/without dexamethasone).&#xD;
•All patients will be randomized to receive either Magnesium sulfate over 1 hour or placebo.•Bronchiolitis severity score (BSS) will be recorded at 0, 4, 8, 12, 16,20,24,36,48,60,72 hours, and on discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>The use of magnesium sulfate intravenous in patient with bronchiolitis in pediatric emergency; follow Broncholitis severity score and length of stay</description>
    <arm_group_label>Magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>use of placebo with standard therapy</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>normal saline for intravenous.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Infants 1-18 months of age presenting to Al Saad Pediatric Emergency Center from October&#xD;
        2012 to May 2015 with diagnosis of Bronchiolitis and bronchiolitis clinical severity score&#xD;
        &gt; 4,will be include in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prematurity (Gestational age 34 weeks or less);&#xD;
&#xD;
          -  Previous history of wheezing;&#xD;
&#xD;
          -  Use of steroid within 48 hours of presentation;&#xD;
&#xD;
          -  CRITICALLY ill patients with one or more of the following:&#xD;
&#xD;
               1. obtunded consciousness&#xD;
&#xD;
               2. progressive respiratory failure requiring intensive care unit (PICU) admission;&#xD;
&#xD;
               3. history of apnea within 24 hours before presentation&#xD;
&#xD;
               4. oxygen saturation &lt; 85% on room air at the time of recruitment&#xD;
&#xD;
          -  History of chronic lung disease;Chronic lung disease of prematurity Cystic fibrosis;&#xD;
&#xD;
          -  Congenital heart disease.&#xD;
&#xD;
          -  All immunodeficient children: primary or secondary&#xD;
&#xD;
          -  Known hypersensitivity to magnesium sulfate.&#xD;
&#xD;
          -  Known to have magnesium or calcium metabolism disturbance. (e.g.; vitamin D&#xD;
             deficiency, hypoparathyroidism).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid M Al-Ansai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rafah F Sayyed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric Emergency Center, Al Saad</name>
      <address>
        <city>Doha</city>
        <zip>465934</zip>
        <country>Qatar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Qatar</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>January 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2014</study_first_posted>
  <last_update_submitted>August 14, 2016</last_update_submitted>
  <last_update_submitted_qc>August 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bronchiolitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

